Home
>
National Drug Code (NDC)
>
Cyclobenzaprine Hydrochloride
Cyclobenzaprine Hydrochloride - 55253-277-60 - (Cyclobenzaprine Hydrochloride)
Drug Information of Cyclobenzaprine Hydrochloride
| Product NDC: | 55253-277 |
| Proprietary Name: | Cyclobenzaprine Hydrochloride |
| Non Proprietary Name: | Cyclobenzaprine Hydrochloride |
| Active Ingredient(s): | 30 mg/1 & nbsp; Cyclobenzaprine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cyclobenzaprine Hydrochloride
| Product NDC: | 55253-277 |
| Labeler Name: | CIMA LABS INC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021777 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110415 |
Package Information of Cyclobenzaprine Hydrochloride
| Package NDC: | 55253-277-60 |
| Package Description: | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (55253-277-60) |
NDC Information of Cyclobenzaprine Hydrochloride
| NDC Code | 55253-277-60 |
| Proprietary Name | Cyclobenzaprine Hydrochloride |
| Package Description | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (55253-277-60) |
| Product NDC | 55253-277 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cyclobenzaprine Hydrochloride |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110415 |
| Marketing Category Name | NDA |
| Labeler Name | CIMA LABS INC |
| Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
